Published in Ann Surg on August 01, 1970
Three closely linked genetic systems relevant to transplantation. Proc Natl Acad Sci U S A (1971) 4.14
Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. J Clin Invest (1972) 1.05
Mixed lymphocyte culture in histocompatiibility testing for familial renal transplantation. Ann Surg (1972) 0.79
Retrospective analysis of 100 consecutive patients undergoing related living donor renal transplantation. Ann Surg (1976) 0.77
Human renal transplantation with donor selection by leukocyte typing. Transplantation (1967) 1.50
Protection of the donor kidney during homotransplantation. Ann Surg (1966) 1.34
Induction of tolerance with antilymphocytic serum. Transplant Proc (1969) 1.06
Immunogenetics of consanguineous allografts in man. I. Histocompatibility testing and skin allografts. Ann Surg (1970) 1.01
Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens. J Clin Invest (1968) 0.98
Selection of recipients and donors for renal transplantation. Arch Intern Med (1969) 0.95
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med (1999) 4.35
Three closely linked genetic systems relevant to transplantation. Proc Natl Acad Sci U S A (1971) 4.14
Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med (1979) 4.09
A simple micro cytotoxicity test. Transplantation (1969) 3.67
HLA-A and B polymorphisms predate the divergence of humans and chimpanzees. Nature (1988) 3.21
Hu-1: Major histocompatibility locus in man. Science (1967) 3.13
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol (1989) 2.32
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med (1999) 2.25
Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol (1986) 2.11
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
Metastatic melanoma in the thorax: report of 130 patients. AJR Am J Roentgenol (1981) 1.95
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg (1995) 1.90
Transplantation of the parathyroid glands in man: clinical indications and results. Surgery (1975) 1.84
Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol (1980) 1.80
Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera. J Exp Med (1975) 1.76
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery (1990) 1.72
Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol (1968) 1.70
New deoxyribonucleic acid polymerase induced by Bacillus subtilis bacteriophage PBS2. J Virol (1972) 1.65
An antigenic determinant of cytotoxic lymphocytes. Transplantation (1973) 1.65
Serological analysis of a recombination in the H-2 region of the mouse. Transplantation (1966) 1.63
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol (1991) 1.60
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg (1994) 1.56
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
Human renal transplantation with donor selection by leukocyte typing. Transplantation (1967) 1.50
Fungal infection following renal transplantation. Arch Intern Med (1975) 1.48
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Shared HLA antigens and reproductive performance among Hutterites. Am J Hum Genet (1983) 1.47
Human histocompatibility locus HL-A. Science (1968) 1.44
Two thymidylate synthetases in Bacillus subtilis. Proc Natl Acad Sci U S A (1978) 1.42
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg (1994) 1.41
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Genetic mapping of Ir locus in man: linkage to second locus of HL-A. Science (1974) 1.41
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology (1993) 1.39
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38
Natural killing in immunodeficient patients. J Immunol (1978) 1.37
Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.37
Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol (1991) 1.35
Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele. Arthritis Rheum (1999) 1.35
Resistance of bacteriophage PBS2 infection to rifampicin, an inhibitor of Bacillus subtilis RNA synthesis. Biochem Biophys Res Commun (1972) 1.34
Cytotoxic lymphocytes in the absence of detectable antibody. Nat New Biol (1973) 1.34
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement. J Immunol (1972) 1.33
Comparison of class I MHC alleles in humans and apes. Immunol Rev (1990) 1.33
Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity. Transplant Rev (1973) 1.32
Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. J Immunol (1975) 1.32
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Skin graft rejection between subjects genotyped for HL-A. Transplant Proc (1969) 1.29
Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (1992) 1.28
Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery (1998) 1.28
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Positron emission tomography scanning in malignant melanoma. Cancer (2000) 1.25
The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens. J Immunol (1980) 1.25
Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med (1976) 1.25
Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J Immunol (1980) 1.24
Peripheral and renal venous plasma renin activity in hypertension. Ann Intern Med (1969) 1.23
Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum Immunol (1980) 1.22
Central nervous system metastases in malignant melanoma. Neurosurgery (1981) 1.21
Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. J Urol (1993) 1.20
Bacillus subtilis deoxyuridinetriphosphatase and its bacteriophage PBS2-induced inhibitor. J Biol Chem (1975) 1.18
Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst (1977) 1.18
A structural gene for bacteriophage T4-induced deoxycytidine triphosphate-deoxyuridine triphosphage nucleotidohydrolase. Virology (1968) 1.18
Selection of patients for heterotopic implantation of the areola and nipple. Surg Gynecol Obstet (1980) 1.17
Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery (1993) 1.16
Surgical treatment of primary hyperaldosteronism. Ann Surg (1994) 1.16
Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg (2001) 1.15
HLA--a central immunological agency of man. Adv Hum Genet (1980) 1.15
Anomalous MLR responsiveness among siblings. Transplant Proc (1971) 1.15
Familial predisposition to filarial infection--not linked to HLA-A or-B locus specificities. Acta Trop (1981) 1.15
Hepatobiliary cystadenoma with mesenchymal stroma. Ann Surg (1990) 1.14
Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway. Science (1972) 1.13
Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg (1992) 1.13
Intraendothelial inclusions in kidneys of patients with systemic lupus erythematosus. Ann Intern Med (1971) 1.13
Resecting and grafting of coronary artery aneurysm. Circulation (1971) 1.12
Second genetic locus in the HLA region for human B-cell alloantigens. Nature (1976) 1.11
Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine. Proc Natl Acad Sci U S A (1978) 1.11
Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med (1980) 1.11
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy. Ann Surg (1989) 1.10
Deoxythymidylate phosphohydrolase induced by bacteriophage PBS2 during infection of Bacillus subtilis. J Biol Chem (1973) 1.10
Mechanisms of immunologic enhancement. Transplant Proc (1970) 1.10
Incidence of anatomical variants in renal vasculature in the presence of normal renal function. Ann Surg (1978) 1.09
The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery (1991) 1.09
Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J Immunol (1984) 1.09
Role of surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg (1991) 1.08
Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet (1983) 1.06
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med (1979) 1.05